211 related articles for article (PubMed ID: 16690975)
21. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
[TBL] [Abstract][Full Text] [Related]
22. Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis.
Urquhart DS; Allen J; Elrayess M; Fidler K; Klein N; Jaffé A
Arch Immunol Ther Exp (Warsz); 2006; 54(4):271-6. PubMed ID: 16830219
[TBL] [Abstract][Full Text] [Related]
23. CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study.
Radtke T; Hebestreit H; Gallati S; Schneiderman JE; Braun J; Stevens D; Hulzebos EH; Takken T; Boas SR; Urquhart DS; Lands LC; Tejero S; Sovtic A; Dwyer T; Petrovic M; Harris RA; Karila C; Savi D; Usemann J; Mei-Zahav M; Hatziagorou E; Ratjen F; Kriemler S;
Ann Am Thorac Soc; 2018 Feb; 15(2):209-216. PubMed ID: 29140739
[TBL] [Abstract][Full Text] [Related]
24. Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapies.
Bresnick K; Arteaga-Solis E; Millar SJ; Laird G; LeCamus C
BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34857524
[TBL] [Abstract][Full Text] [Related]
25. CFTR genotype as a predictor of prognosis in cystic fibrosis.
McKone EF; Goss CH; Aitken ML
Chest; 2006 Nov; 130(5):1441-7. PubMed ID: 17099022
[TBL] [Abstract][Full Text] [Related]
26. Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles.
Terlizzi V; Castaldo G; Salvatore D; Lucarelli M; Raia V; Angioni A; Carnovale V; Cirilli N; Casciaro R; Colombo C; Di Lullo AM; Elce A; Iacotucci P; Comegna M; Scorza M; Lucidi V; Perfetti A; Cimino R; Quattrucci S; Seia M; Sofia VM; Zarrilli F; Amato F
J Med Genet; 2017 Apr; 54(4):224-235. PubMed ID: 27738188
[TBL] [Abstract][Full Text] [Related]
27. Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.
McCague AF; Raraigh KS; Pellicore MJ; Davis-Marcisak EF; Evans TA; Han ST; Lu Z; Joynt AT; Sharma N; Castellani C; Collaco JM; Corey M; Lewis MH; Penland CM; Rommens JM; Stephenson AL; Sosnay PR; Cutting GR
Am J Respir Crit Care Med; 2019 May; 199(9):1116-1126. PubMed ID: 30888834
[No Abstract] [Full Text] [Related]
28. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
[TBL] [Abstract][Full Text] [Related]
29. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
30. [Genotypes of cystic fibrosis (CF) reported in the world and polymorphisms of cystic fibrosis transmembrane conductance regulator (CFTR) gene in Japanese].
Wang W; Okayama H; Shirato K
Nihon Rinsho; 1996 Feb; 54(2):525-32. PubMed ID: 8838109
[TBL] [Abstract][Full Text] [Related]
31. Identification of SNPs in the cystic fibrosis interactome influencing pulmonary progression in cystic fibrosis.
Gisler FM; von Kanel T; Kraemer R; Schaller A; Gallati S
Eur J Hum Genet; 2013 Apr; 21(4):397-403. PubMed ID: 22892532
[TBL] [Abstract][Full Text] [Related]
32. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
33. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
[TBL] [Abstract][Full Text] [Related]
34. Cystic fibrosis transmembrane conductance regulator gene mutations and glutathione S-transferase null genotypes in cystic fibrosis patients in Brazil.
Lima CS; Ortega MM; Marson FA; Zulli R; Ribeiro AF; Bertuzzo CS
J Bras Pneumol; 2012; 38(1):50-6. PubMed ID: 22407040
[TBL] [Abstract][Full Text] [Related]
35. Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.
Polineni D; Dang H; Gallins PJ; Jones LC; Pace RG; Stonebraker JR; Commander LA; Krenicky JE; Zhou YH; Corvol H; Cutting GR; Drumm ML; Strug LJ; Boyle MP; Durie PR; Chmiel JF; Zou F; Wright FA; O'Neal WK; Knowles MR
Am J Respir Crit Care Med; 2018 Jan; 197(1):79-93. PubMed ID: 28853905
[TBL] [Abstract][Full Text] [Related]
36. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.
Kubesch P; Dörk T; Wulbrand U; Kälin N; Neumann T; Wulf B; Geerlings H; Weissbrodt H; von der Hardt H; Tümmler B
Lancet; 1993 Jan; 341(8839):189-93. PubMed ID: 7678316
[TBL] [Abstract][Full Text] [Related]
37. Correlations between cystic fibrosis genotype and sinus disease severity in chronic rhinosinusitis.
Abuzeid WM; Song C; Fastenberg JH; Fang CH; Ayoub N; Jerschow E; Mohabir PK; Hwang PH
Laryngoscope; 2018 Aug; 128(8):1752-1758. PubMed ID: 29193105
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.
Magalhães M; Rivals I; Claustres M; Varilh J; Thomasset M; Bergougnoux A; Mely L; Leroy S; Corvol H; Guillot L; Murris M; Beyne E; Caimmi D; Vachier I; Chiron R; De Sario A
Clin Epigenetics; 2017; 9():19. PubMed ID: 28289476
[TBL] [Abstract][Full Text] [Related]
39. Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology.
Procianoy EDFA; de Abreu E Silva FA; Maróstica PJC; Quinton PM
Lung; 2020 Feb; 198(1):151-156. PubMed ID: 31734731
[TBL] [Abstract][Full Text] [Related]
40. Cystic fibrosis transmembrane conductance regulator function, not TAS2R38 gene haplotypes, predict sinus surgery in children and young adults with cystic fibrosis.
Dalesio NM; Aksit MA; Ahn K; Raraigh KS; Collaco JM; McGrath-Morrow S; Zeitlin PL; An SS; Cutting GR
Int Forum Allergy Rhinol; 2020 Jun; 10(6):748-754. PubMed ID: 32282124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
